Onesource Specialty Pharma: Intimation Regarding Receipt Of No Objection/ No Adverse Observation Letter From The National Stock Exchange Of India Limited / BSE Limited In Realation To The Draft Composite Scheme Of Arrangement And Amalgamation (Merger By Absorption).

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

For grievances: [email protected]